Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors. 2010

Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
College of Life Science and Bio-engineering, Beijing University of Technology, Pingleyuan Street No. 100, Chaoyang District, Beijing 100124, China.

A series of N-aryl-2-arylthioacetamide derivatives (2-4) designed as non-nucleoside reverse transcriptase inhibitors was synthesized and evaluated for their inhibitory activity against HIV-1 (IIIB) replication in MT-4 cell cultures. The compounds 2-4 were performed by the reaction of thiols and 2-chloro-N-substituted-acetamides and active in the lower micromolar concentration (1.25-20.83 μM). The studies of structure-activity relationship suggested that 1H-benzo[d]imidazole ring at arylthio moiety strongly improved the anti-HIV activity and consistent with the experimental data. The results of molecular modeling and docking within the RT non-nucleoside binding site using AutoDock confirmed that the 3 series, similar to other non-nucleoside reverse transcriptase inhibitors such as N-(5-chloro-2-pyridinyl)-N'-[2-(4-ethoxy-3-fluoro-2-pyridinyl)ethyl]-thiourea (PETT), was assumed in a butterfly-like conformation and helped to rationalize some SARs and the biological activity data.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D013853 Thioacetamide A crystalline compound used as a laboratory reagent in place of HYDROGEN SULFIDE. It is a potent hepatocarcinogen. Thiacetamid,Thioacetamid
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
January 2011, Journal of medicinal chemistry,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
February 2014, Bioorganic & medicinal chemistry,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
June 2014, Bioorganic & medicinal chemistry,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
March 2015, Chemical biology & drug design,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
August 2011, Bioorganic & medicinal chemistry,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
August 2009, Bioorganic & medicinal chemistry,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
January 2006, Antiviral chemistry & chemotherapy,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
January 2020, Bioorganic chemistry,
Zhu Xiaohe, and Qin Yu, and Yan Hong, and Song Xiuqing, and Zhong Rugang
February 2019, ACS medicinal chemistry letters,
Copied contents to your clipboard!